Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-20 · accession 0000875320-24-000076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-21 | 2024-02-20 | VRTX | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $420.58 | -4,118 | 13.8K | -23% | -$1.73M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | F | D | 4,118 | $420.58 | 13,778 | D | — | — |